ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011